Cargando…
The place for remdesivir in COVID-19 treatment
Autores principales: | Young, Barnaby, Tan, Thuan Tong, Leo, Yee Sin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837362/ https://www.ncbi.nlm.nih.gov/pubmed/33248473 http://dx.doi.org/10.1016/S1473-3099(20)30911-7 |
Ejemplares similares
-
Remdesivir for COVID-19: challenges of underpowered studies
por: Norrie, John David
Publicado: (2020) -
Remdesivir for COVID-19 in Europe: will it provide value for money?
por: Dal-Ré, Rafael, et al.
Publicado: (2021) -
Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir
por: Chan, Yi-Hao, et al.
Publicado: (2021) -
Remdesivir, on the road to DisCoVeRy
por: Gyselinck, Iwein, et al.
Publicado: (2022) -
When and which patients should receive remdesivir?
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)